Form 4 for RMD ResMed|
Accepted 2024-11-12 00:00:00 ET · period of report 2024-11-08 · accession 0001127602-24-027030 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-11-12 | 2024-11-08 | RMD | Sandercock Brett | CFO | S - Sale | $249.00 | -1,000 | 94.9K | -1% | -$249.0K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | ResMed Common Stock | 2024-11-08 | S | D | 1,000 | $249.00 | 94,864 | D | — | — | (F2) Includes 51.807 shares of ResMed stock purchased on October 31, 2024, through the ResMed Employee Stock Purchase Plan. |